Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Process for Qualifying Impurities (3 of 4)
9:58
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Process for Qualifying Impurities (3 of 4)
9:58
|
Product and Process Impurities Analysis
3:40
|
ICH Q3A l Impurities in New Drug substance l impurities in pharma industry l Question and answers
8:41
|
Analytical Package, CMC and Impurities (5 of 6)
13:52
|
[Quality] Q3A(R2)
46:06
|
How to define limit for unknown, known and total impurities
26:07
|
Purity is a Virtue: A Practical Guide to the Reporting of Impurities
55:13
|
Webinar | Developing Impurities Analytical Methods with a Quality and Risk-Based Approach
1:05:57
|
How to cure Constipation, Indigestion, Poor Bowel Movement Naturally in 4 Simple steps at Home
7:00
|
Selected Case Studies and Impurity Strategies for Drug Substances by Paul Wrezel, Ph.D. (Full)
21:53
|
Effective Workflow for Pharmaceutical Impurity Analysis using HR- LCMS
2:20
|
Selected Case Studies and Impurity Strategies for Drug Substances Part III: Exercise & Conclusion
6:04
|
DMF section 3.2.S.4 - Control of drug substance
4:32
|
Identified Impurity,Unidentified Impurity, Specified Impurity , Unspecified Impurity as per ICH Q3A
7:27
|
Selected Case Studies and Impurity Strategies for Drug Substances Part I: Introduction to PGIs
7:59
|
Elemental Impurities as per ICH Q3D guideline.
10:53
|
DMF section 3.2.S.3 - Characterization
6:20
|
Genotoxic Impurities (4 of 4)
22:20
|
Impurity Case Studies: Pharmacology/Toxicology (22of28) Generic Drugs Forum – Apr. 3-4, 2019
25:40
|
Elemental Impurities Webinar with Azierta
1:26:58
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa